Strategies to improve detection of hypertension genes

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Multiple factors contribute to the development of hypertension, including genetic factors and environmental exposures. Various pathophysiological mechanisms are at play in the pathogenesis of hypertension and this pathogenesis, by necessity, exhibits substantial variation at the level of the individual, as it depends on the relative contribution of inherited genes and individual lifetime environmental exposures. Over time, long-term compensatory mechanisms, including responses to either chronic hypertension or to therapeutic intervention, can only obscure the initiating mechanisms of disease. Acute compensating mechanisms can also mask initiating gene effects during or after an intervention, so that early phenotype assessments during the intervention may be more likely to detect the genetic initiators. Compensatory mechanisms, working over days, weeks or even years, will likely be variably effective in minimizing the expected blood pressure rise, making it difficult to detect genetic initiating mechanisms in cross-sectional, 'steady state', or 'in balance' studies. If the lifetime risk of hypertension indeed approaches 90% [13], the power to identify genetic factors can only decrease with duration of disease and treatment, and prediction of hypertension becomes of vanishing significance. With multiple factors at play, we cannot expect that all causes are mutually exclusive, but it is reasonable to assume that one of these mechanisms is predominant in the initiation of the disease in any one individual. Given the heterogeneity of essential hypertension argued above, it becomes evident that the chance of identifying genetic factors that contribute to disease development will be greatest if study subjects at highest genetic predisposition are observed during age ranges when heritability is at a maximum, using the correct phenotypes, measured in the correct tissues, during the correct time window. Genes found to be significant in such studies should be densely typed in clinical trials and large population studies to assess public health and clinical applications of the findings.

Original languageEnglish
Title of host publicationPersonalized Nutrition,Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines"
Pages46-55
Number of pages10
Volume101
DOIs
Publication statusPublished - 2010
Externally publishedYes

Publication series

NameWorld Review of Nutrition and Dietetics
Volume101
ISSN (Print)00842230
ISSN (Electronic)16623975

Fingerprint

hypertension
Hypertension
Genes
Environmental Exposure
genes
Phenotype
pathogenesis
phenotype
Genetic Predisposition to Disease
Masks
balance studies
Public Health
blood pressure
Clinical Trials
clinical trials
public health
Blood Pressure
heritability
therapeutics
duration

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this

Hunt, S. (2010). Strategies to improve detection of hypertension genes. In Personalized Nutrition,Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines" (Vol. 101, pp. 46-55). (World Review of Nutrition and Dietetics; Vol. 101). https://doi.org/10.1159/000314510

Strategies to improve detection of hypertension genes. / Hunt, Steven.

Personalized Nutrition,Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines". Vol. 101 2010. p. 46-55 (World Review of Nutrition and Dietetics; Vol. 101).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Hunt, S 2010, Strategies to improve detection of hypertension genes. in Personalized Nutrition,Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines". vol. 101, World Review of Nutrition and Dietetics, vol. 101, pp. 46-55. https://doi.org/10.1159/000314510
Hunt S. Strategies to improve detection of hypertension genes. In Personalized Nutrition,Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines". Vol. 101. 2010. p. 46-55. (World Review of Nutrition and Dietetics). https://doi.org/10.1159/000314510
Hunt, Steven. / Strategies to improve detection of hypertension genes. Personalized Nutrition,Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines". Vol. 101 2010. pp. 46-55 (World Review of Nutrition and Dietetics).
@inproceedings{efa39944960847e7a2b65a46356c6860,
title = "Strategies to improve detection of hypertension genes",
abstract = "Multiple factors contribute to the development of hypertension, including genetic factors and environmental exposures. Various pathophysiological mechanisms are at play in the pathogenesis of hypertension and this pathogenesis, by necessity, exhibits substantial variation at the level of the individual, as it depends on the relative contribution of inherited genes and individual lifetime environmental exposures. Over time, long-term compensatory mechanisms, including responses to either chronic hypertension or to therapeutic intervention, can only obscure the initiating mechanisms of disease. Acute compensating mechanisms can also mask initiating gene effects during or after an intervention, so that early phenotype assessments during the intervention may be more likely to detect the genetic initiators. Compensatory mechanisms, working over days, weeks or even years, will likely be variably effective in minimizing the expected blood pressure rise, making it difficult to detect genetic initiating mechanisms in cross-sectional, 'steady state', or 'in balance' studies. If the lifetime risk of hypertension indeed approaches 90{\%} [13], the power to identify genetic factors can only decrease with duration of disease and treatment, and prediction of hypertension becomes of vanishing significance. With multiple factors at play, we cannot expect that all causes are mutually exclusive, but it is reasonable to assume that one of these mechanisms is predominant in the initiation of the disease in any one individual. Given the heterogeneity of essential hypertension argued above, it becomes evident that the chance of identifying genetic factors that contribute to disease development will be greatest if study subjects at highest genetic predisposition are observed during age ranges when heritability is at a maximum, using the correct phenotypes, measured in the correct tissues, during the correct time window. Genes found to be significant in such studies should be densely typed in clinical trials and large population studies to assess public health and clinical applications of the findings.",
author = "Steven Hunt",
year = "2010",
doi = "10.1159/000314510",
language = "English",
isbn = "9783805594271",
volume = "101",
series = "World Review of Nutrition and Dietetics",
pages = "46--55",
booktitle = "Personalized Nutrition,Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines{"}",

}

TY - GEN

T1 - Strategies to improve detection of hypertension genes

AU - Hunt, Steven

PY - 2010

Y1 - 2010

N2 - Multiple factors contribute to the development of hypertension, including genetic factors and environmental exposures. Various pathophysiological mechanisms are at play in the pathogenesis of hypertension and this pathogenesis, by necessity, exhibits substantial variation at the level of the individual, as it depends on the relative contribution of inherited genes and individual lifetime environmental exposures. Over time, long-term compensatory mechanisms, including responses to either chronic hypertension or to therapeutic intervention, can only obscure the initiating mechanisms of disease. Acute compensating mechanisms can also mask initiating gene effects during or after an intervention, so that early phenotype assessments during the intervention may be more likely to detect the genetic initiators. Compensatory mechanisms, working over days, weeks or even years, will likely be variably effective in minimizing the expected blood pressure rise, making it difficult to detect genetic initiating mechanisms in cross-sectional, 'steady state', or 'in balance' studies. If the lifetime risk of hypertension indeed approaches 90% [13], the power to identify genetic factors can only decrease with duration of disease and treatment, and prediction of hypertension becomes of vanishing significance. With multiple factors at play, we cannot expect that all causes are mutually exclusive, but it is reasonable to assume that one of these mechanisms is predominant in the initiation of the disease in any one individual. Given the heterogeneity of essential hypertension argued above, it becomes evident that the chance of identifying genetic factors that contribute to disease development will be greatest if study subjects at highest genetic predisposition are observed during age ranges when heritability is at a maximum, using the correct phenotypes, measured in the correct tissues, during the correct time window. Genes found to be significant in such studies should be densely typed in clinical trials and large population studies to assess public health and clinical applications of the findings.

AB - Multiple factors contribute to the development of hypertension, including genetic factors and environmental exposures. Various pathophysiological mechanisms are at play in the pathogenesis of hypertension and this pathogenesis, by necessity, exhibits substantial variation at the level of the individual, as it depends on the relative contribution of inherited genes and individual lifetime environmental exposures. Over time, long-term compensatory mechanisms, including responses to either chronic hypertension or to therapeutic intervention, can only obscure the initiating mechanisms of disease. Acute compensating mechanisms can also mask initiating gene effects during or after an intervention, so that early phenotype assessments during the intervention may be more likely to detect the genetic initiators. Compensatory mechanisms, working over days, weeks or even years, will likely be variably effective in minimizing the expected blood pressure rise, making it difficult to detect genetic initiating mechanisms in cross-sectional, 'steady state', or 'in balance' studies. If the lifetime risk of hypertension indeed approaches 90% [13], the power to identify genetic factors can only decrease with duration of disease and treatment, and prediction of hypertension becomes of vanishing significance. With multiple factors at play, we cannot expect that all causes are mutually exclusive, but it is reasonable to assume that one of these mechanisms is predominant in the initiation of the disease in any one individual. Given the heterogeneity of essential hypertension argued above, it becomes evident that the chance of identifying genetic factors that contribute to disease development will be greatest if study subjects at highest genetic predisposition are observed during age ranges when heritability is at a maximum, using the correct phenotypes, measured in the correct tissues, during the correct time window. Genes found to be significant in such studies should be densely typed in clinical trials and large population studies to assess public health and clinical applications of the findings.

UR - http://www.scopus.com/inward/record.url?scp=77956083941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956083941&partnerID=8YFLogxK

U2 - 10.1159/000314510

DO - 10.1159/000314510

M3 - Conference contribution

C2 - 20436252

SN - 9783805594271

VL - 101

T3 - World Review of Nutrition and Dietetics

SP - 46

EP - 55

BT - Personalized Nutrition,Translating Nutrigenetic/Nutrigenomic Research into Dietary Guidelines"

ER -